Skip to content

IDEAYA Biosciences, Inc. IDYA Q4 2024 Annual earnings

Reported February 13, 2025 · Before market open

Revenue$7.0MBeat by $4.5M
EPS-$1.49Miss by $0.82
Revenue estimate$2.5M
EPS estimate-$0.67

Next report

Aug 10, 2026 (In 1 week)
Revenue estimate$8.0M
EPS estimate-$1.06

Financials

Q4 2024

Income statement

See full
Revenue$7.0M+78.5%
Operating income-$144.1M-244%
Net income-$130.3M-284%
EPS (diluted)-$1.55-198%

Balance sheet

See full
Cash & equivalents$84.4M-46.3%
Total debt$19.2M+568%
Total equity$1.1B+70.5%
Total assets$1.1B+73.1%

Cash flow

See full
Operating cash flow-$121.7M-412%
CapEx$1.1M+31.5%
Free cash flow-$122.8M-399%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$2.22B-4.3%
Enterprise value$2.16B-0.5%
P/S317.3×+218×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-32.7%+22.1pp
Debt / equity0.0×
Current ratio15×-4.7×

Versus estimates

Ask the moment IDEAYA Biosciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did IDEAYA Biosciences, Inc. report Q4 2024 earnings?
IDEAYA Biosciences, Inc. (IDYA) reported Q4 2024 earnings on February 13, 2025 before market open.
What were IDEAYA Biosciences, Inc.'s Q4 2024 revenue and EPS?
IDEAYA Biosciences, Inc. reported revenue of $7.0M and eps of $-1.49 for Q4 2024.
Did IDEAYA Biosciences, Inc. beat estimates in Q4 2024?
Revenue beat the consensus estimate of $2.5M by $4.5M. EPS missed the consensus estimate of $-0.67 by $0.82.
Where can I find IDEAYA Biosciences, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-022183) directly on SEC EDGAR. The filing index links above go to sec.gov.